VRCA

Verrica Pharmaceuticals Inc.

Healthcare · Biotechnology

$240.79 sample

-3.42 (-1.40%) 1D

Market cap

$1.43T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-07

Alerts

8

Price$240.79 +2.52% 3M daily closessample

246.31225.04

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: Chief Financial Officer
Oct 08INSInsider buy: EVP, Operations
Oct 02INSInsider sell: Chief Financial Officer
Sep 28INSInsider sell: 10% owner
Sep 23INSInsider sell: EVP, Operations
Sep 18INSInsider sell: EVP, Operations
Sep 10INSInsider sell: General Counsel
Sep 07SECDEF 14A filed

Sign up to see the real VRCA record →

Company facts

SEC EDGAR registration

Name: Verrica Pharmaceuticals Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +35sample, -100 to +100
Reporting currency: USD

Who is positioning in VRCA

sample

Insiders: 11 insider transactions over 90 days, net selling, $189.9M
Congress: No member trades over 90 days
Institutions · 13F: 44 funds hold $31.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$55.5B +19.3% y/y

Q4 2024Q3 2026

Inventory$30.9B +8.2% y/y

Q4 2024Q3 2026

Accounts receivable$24.3B +9.9% y/y

Q4 2024Q3 2026

Total debt$66.8B +11.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $585.1B +13.9% 3M
Sample peer B: $665.4B +8.4% 3M
Sample peer C: $890.9B +12.9% 3M
Sample peer D: $713.4B -9.9% 3M
Sample peer E: $1.05T +0.2% 3M